ArticleDiabetology & metabolic syndrome2024

Effects of finerenone and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus: a systematic review and meta-analysis.

Xia Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.